Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinephrine effect on mepivacaine absorption in brachial plexus block for ESRD
2012-000948-98Phase 4Terminated
- Sponsor
- Rigshospitalet
- Start
- May 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of epinephrine and mepivacaine in end-stage kidney disease (ESKD) (2 arms), sponsored by Rigshospitalet. Primary endpoint: Plasma concentration of mepivacaine. Started May 2012; status: terminated.
02
Drugs
epinephrinemepivacaine
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2012-000948-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000948-98.